Teen With Crohn’s Shares Journey To Remission And Advocacy
A teenager's decade-long battle with Crohn's disease leads to remission and a mission to inspire others facing similar challenges.
A courageous teenager’s story of living with Crohn’s disease highlights the challenges of pediatric IBD, the pursuit of effective treatments, and the power of hope and advocacy.
Early Signs and Diagnosis
Crohn’s disease, a type of inflammatory bowel disease (IBD), often strikes during adolescence, disrupting normal growth and daily life. For Maddie, symptoms began just as she started sixth grade in 2009. She experienced severe abdominal pain, weight loss, bloody stools, joint pain, and frequent fevers—classic indicators of GI tract inflammation characteristic of Crohn’s.
Diagnosed promptly, Maddie was started on steroids and oral medications. However, these provided only partial relief. A brief hospitalization followed, leading to Remicade infusions, a biologic therapy commonly used to suppress inflammation in Crohn’s patients. While infusions helped, full remission required six weeks of intravenous steroids.
Nutritional concerns are prevalent in up to 65%-85% of pediatric Crohn’s cases, with underweight, stunting, and growth delays common at presentation. Maddie’s experience underscores how early intervention is crucial, yet initial treatments often fall short without comprehensive management.
Complications and Treatment Hurdles
Remission was short-lived. By fall 2010, Maddie developed severe eczema and psoriasis on her feet, rendering walking impossible. Suspected as side effects from Remicade, these conditions complicated her care. Weekly dermatology treatments failed, forcing a search for alternatives.
An insurance issue in early 2011 necessitated a new provider, leading Maddie to Dr. Ashish Patel, Director of the Southwestern Pediatric IBD Program at Children’s Health. A colonoscopy confirmed a disease flare. Dr. Patel’s thorough research and collaboration with national experts marked a turning point.
Over the next years, trials included an eight-month period of exclusive enteral nutrition (EEN) via NG tube, halting oral intake to rest the GI tract. EEN induces remission and improves nutrition comparably to corticosteroids, with benefits for bone health and growth. Despite this, results were suboptimal.
A promising new medication triggered anaphylactic shock during the fourth infusion, exhausting standard options. Growth deficiency affects up to 85% of pediatric Crohn’s patients, often preceding bowel symptoms and impacting quality of life. Maddie’s persistent challenges highlight the need for personalized, aggressive approaches.
Finding the Right Treatment Path
Facing limited options, Dr. Patel proposed an off-label medication typically used for psoriasis, showing promise in adult Crohn’s trials. Though not FDA-approved for pediatrics, advocacy secured approval. This therapy finally achieved sustained remission, allowing Maddie to resume normal activities like school, friendships, and art.
Early “top-down” immunomodulatory therapy, including biologics, is recommended to control inflammation, promote catch-up growth, and prevent puberty delays. Recombinant growth hormone offers short-term height gains in select cases but doesn’t address mucosal healing. Maddie’s success validates innovative, multidisciplinary care.
Impact on Growth and Development
Pediatric Crohn’s frequently causes linear growth retardation and delayed puberty due to chronic inflammation and malnutrition. Studies show 65%-85% of children present with growth issues, with 15%-40% facing lifelong deficits without early control.
Maddie’s journey involved monitoring skeletal age via radiology to assess growth potential. Avoiding prolonged corticosteroids—linked to bone density loss—is vital; EEN normalizes bone turnover markers post-therapy. Her remission enabled developmental catch-up, emphasizing timely intervention before puberty.
| Challenge | Prevalence | Management Strategy |
|---|---|---|
| Growth Deficiency | 65%-85% | EEN, biologics, growth hormone |
| Undernutrition | 65%-75% | Nutritional therapy, remission induction |
| Delayed Puberty | Up to 85% | Inflammation control, nutrient optimization |
| Bone Health Issues | Persistent low BMD | Avoid steroids, EEN for turnover normalization |
This table summarizes key issues from clinical reviews, guiding holistic care.
Emotional and Social Toll
Beyond physical symptoms, Crohn’s imposes psychological burdens. Hospitalizations, infusions, and dietary restrictions isolate teens from peers. Art became Maddie’s outlet, helping process school stress and illness.
Family support is pivotal; Maddie’s mother, Kristie, navigated insurance woes and treatment trials. Adolescents face cosmetic concerns from steroids, amplifying adolescence’s vulnerabilities. Remission restored balance, enabling social engagement.
Advocacy and Giving Back
Now thriving, Maddie channels resilience into advocacy. With her mother, she joins ImproveCareNow, an international initiative enhancing IBD care. They attend conferences with Dr. Patel, sharing patient perspectives to improve pediatric outcomes.
Such stories inspire, reducing stigma and promoting awareness. Programs like Children’s Health Southwestern Pediatric IBD Program offer multidisciplinary expertise, from gastroenterology to nutrition.
Current Treatment Landscape
Pediatric Crohn’s management evolves. Exclusive enteral nutrition remains first-line for induction, matching steroid efficacy without growth-suppressing side effects. Biologics like anti-TNF agents (e.g., Remicade) target inflammation, though allergies or resistance occur.
Emerging therapies, including psoriasis drugs, expand options. Long-term goals: mucosal healing, growth normalization, and quality-of-life preservation. Multidisciplinary teams address GI, nutritional, and psychological needs.
Frequently Asked Questions (FAQs)
What are common symptoms of Crohn’s in teens?
Symptoms include abdominal pain, diarrhea with blood, weight loss, fatigue, joint pain, and fevers. Growth delays may precede GI issues.
How does Crohn’s affect growth in children?
Chronic inflammation and poor nutrition cause stunting in 65%-85% of cases. Early remission via EEN or biologics enables catch-up growth.
What is exclusive enteral nutrition (EEN)?
EEN provides all nutrition via formula, inducing remission like steroids while improving bone health and nutrition without side effects.
Can Crohn’s be cured in teenagers?
No cure exists, but remission is achievable with tailored therapies. Stories like Maddie’s show sustained control is possible.
How can families support a teen with Crohn’s?
Seek specialist care, advocate for innovative treatments, encourage outlets like art, and join support networks like ImproveCareNow.
Hope for the Future
Maddie’s decade-long journey—from diagnosis to experimental success—exemplifies perseverance. Pediatric IBD programs advance care, offering hope. Early, aggressive treatment maximizes growth and life quality, turning challenges into advocacy.
References
- Crohn’s disease and growth deficiency in children and adolescents — PMC/NCBI. 2014-09-14. https://pmc.ncbi.nlm.nih.gov/articles/PMC4188880/
- A Teen’s Long Journey Leads to Hope and Helping Others with Crohn’s — Children’s Health. Accessed 2026. https://www.childrens.com/health-wellness/a-teens-long-journey-leads-to-hope-and-helping-others-with-crohns
Similar Articles
Read full bio of medha deb
